Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 24.6.2024Teva B.V. (TEV-NL-4)91373Gabapentin-Teva 300 mg (cps dur 50x300 mg (blis.PVC/PVDC/Al))24.6.2024O
 24.6.2024Teva B.V. (TEV-NL-4)1220BSastravi 150 mg/37,5 mg/200 mg (tbl flm 100x150 mg/37,5 mg/200 mg (obal HDPE))19.8.2024Z
 24.6.2024Johnson & Johnson, s.r.o. (JHN-SK-1)49926Concerta 54 mg tablety s predĺženým uvoľňovaním (tbl plg 30x54 mg (fľ.HDPE))21.6.2024O
 24.6.2024B.Braun Melsungen AG (BME)80553Braunol (sol der 1x1000 ml (fľ.PE))24.6.2024R
 21.6.2024B.Braun Melsungen AG (BME)13907Chlorid sodný B. Braun 0,9 % infúzny roztok (sol inf 10x1000 ml (fľ.PE))21.6.2024O
 21.6.2024Viatris Healthcare Limited (VIM-1)26526Kreon 10 000 (cps end 50x150 mg (fľ.HDPE))24.6.2024R
 21.6.2024AbbVie Deutschland GmbH & Co. KG (ABV-DE)3297DRINVOQ 15 mg tablety s predĺženým uvoľňovaním (tbl plg 98 (2x49)x15 mg (blis.PVC/PE/PCTFE/Al))1.6.2024U
 21.6.2024Takeda Manufacturing Austria AG (TKM-5)97250KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x200 ml/20 g (liek.inj.skl.))21.6.2024R
 21.6.2024Santen Oy (SOY)78612TAFLOTAN (int opo 90 (9x10)x0,3 ml/4,5 µg (obal LDPE jednodávk.))24.6.2024O
 21.6.2024Merck Sharp & Dohme B.V. (MSD-NL)14675VAQTA 25 U (sus inj 1x0,5 ml/25 U (striek.inj.napl.s dvoma ihlami))21.6.2024O
 20.6.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2061CAtomoxetine Sandoz 10 mg (cps dur 28x10 mg (blis.PVC/PE/PCTFE/Al))17.6.2024R
 20.6.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2071CAtomoxetine Sandoz 18 mg (cps dur 28x18 mg (blis.PVC/PE/PCTFE/Al))17.6.2024R
 20.6.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2081CAtomoxetine Sandoz 25 mg (cps dur 28x25 mg (blis.PVC/PE/PCTFE/Al))17.6.2024R
 20.6.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2091CAtomoxetine Sandoz 40 mg (cps dur 28x40 mg (blis.PVC/PE/PCTFE/Al))17.6.2024R
 20.6.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2101CAtomoxetine Sandoz 60 mg (cps dur 28x60 mg (blis.PVC/PE/PCTFE/Al))17.6.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)